http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104169297-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 |
| filingDate | 2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104169297-B |
| titleOfInvention | Target the monoclonal antibody of the neutralizing epitope on the H5 influenza viruses of clade 2.3 |
| abstract | The present invention relates to mouse monoclonal antibody C, F and H and its active fragment of the main neutralizing epitope of the H5 influenza hemagglutinins of targeting clade 2.3.The method and composition of H5N1 influenzas is prevented and treated the invention further relates to mouse monoclonal antibody C, F or H or its active fragment is used.The invention additionally relates to the method and compositions that the general protection for H5 influenza viruses is provided using mouse monoclonal antibody C, F or H or its segment and complementary mouse monoclonal antibody or its active fragment.The invention further relates to the method and compositions for using these mouse monoclonal antibodies or its segment characterizes and quantitative H5 is expressed. |
| priorityDate | 2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 150.